Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02519894
Other study ID # Ramathibodi Hospital
Secondary ID
Status Enrolling by invitation
Phase N/A
First received August 9, 2015
Last updated August 9, 2015
Start date August 2015
Est. completion date August 2016

Study information

Verified date August 2015
Source Ramathibodi Hospital
Contact n/a
Is FDA regulated No
Health authority Thailand: Ethical Committee
Study type Interventional

Clinical Trial Summary

Introduction :

Due to Chronic kidney disease is a public health problem, which is important increased in both developed and developing countries . And sodium intake restriction was related to the reduction of blood pressure and urine protein which is one of the important risk factor in chronic kidney disease. One of the problem in sodium restriction failure in Thai population with CKD nowadays is lack of knowledge and problem unawareness.

The study hypothesis :

Intense knowledge about sodium reduction and immediate feedback of the sodium intake could be simultaneously modifying the behavior to reduce sodium intake , blood pressure and also GFR reduction rate

Objectives :

To compare the effect of dietary salt restriction on glomerular filtration rate (GFR) between CKD patients receiving strict controlled combined with immediate individual feedback (DISC Progrram) and those receiving standard education.

Study design :

Multicenter, open labeled, parallel, randomized controlled trial

Sample size : 600

Primary outcome : GFR reduction (CKD-EPI)

Secondary outcome :

- Achievement rate of Na intake < 2 g/day (Urine Na < 90 mEq/day)

- Blood pressure difference

- Proportions of patients with BP reached the target (130/80 mmHg)

- Number of anti-hypertensive drugs use to achieve BP target

- Urine albumin/creatinine ratio

- Major Adverse Cardiac Events (MACE)

- Cardio-ankle vascular index (CAVI)

- ankle-brachial index (ABI)

Documentary Proof of Ethical Clearance :

This project has been reviewed and approved by the Comittee on Human Rights Related to Research Involving Human Subjects , based on the declaration of Helsinki


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 600
Est. completion date August 2016
Est. primary completion date August 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- CKD stage 3-4 (eGFR 15-59 mL/min/1.73m²)

- Microalbuminuria

- Any blood pressure level

Exclusion Criteria:

- Salt - losing conditions

- Hyponatremia (Na < 135 mg/dL) or Hypernatremia (Na > 145 mg/dL)

- Bilateral renal artery stenosis

- Severe comorbid disease or life expectancy <1 year (severe cardiovascular disease, chronic liver disease, severe infection , malignancy)

- Immunosuppressant used

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Behavioral:
Dietary Scanning Calculator


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
PANTHITA SORNHIRAN

Outcome

Type Measure Description Time frame Safety issue
Primary The declination of glomerular infiltration rate one year Yes